1V-LSD Pellets – 225mcg

Introduction

1V‑LSD Pellets – 225mcg are a 1V‑LSD research chemical formulated as solid, compact pellets, with each unit labeled at 225mcg to support consistent, contamination‑minimized dosing in analytical and laboratory‑based experiments. The pellet format simplifies storage, handling, and mass transfer compared with bulk powder, making it particularly suitable for research environments that require clearly defined, easily counted units for precise preparation and documentation. This product is supplied exclusively for research‑grade lysergamide work and is not intended for any application involving human or animal ingestion, treatment, or diagnostic use.

Scientific Overview

1V‑LSD (1‑valeroyl‑lysergic acid diethylamide; commonly known by the research‑compound alias “Valerie”) is a semisynthetic lysergamide closely related to LSD, in which the lysergamide core is modified by a valeroyl (pentanoyl) acyl group attached to the indole‑nitrogen, creating a distinct N1‑substituted lysergamide structure. Within the existing research‑chemical literature, lysergamides of this structural class are typically investigated for their physicochemical properties, chromatographic profile, and receptor‑binding behavior under strictly controlled and non‑clinical conditions. 1V‑LSD Pellets – 225mcg are supplied strictly as a laboratory‑grade lysergamide reference substance and must not be used for diagnostic, therapeutic, or consumer‑oriented applications.

Product Specifications

• Product Name: 1V‑LSD Pellets – 225mcg.

• Chemical Name: 1‑Valeroyl‑lysergic acid diethylamide (often supplied as the hemi‑L‑tartrate salt).

• CAS Number: 3028950‑70‑8.

• Compound Class: Novel lysergamide research chemical.

• Form: Solid pellets.

• Dosage per Unit: 225mcg per pellet.

• Purity: Typically ≥ 98–99% research‑grade, where confirmed by analytical methods such as HPLC, NMR, or mass spectrometry.

• Molecular Formula: C₂₃H₂₉N₃O (freebase) or related salt‑derived stoichiometry depending on formulation.

• Molecular Weight: Approximately 365–367 g/mol, depending on salt form.

• Appearance: Uniform, off‑white to light‑beige pellets.

• Quantity: Available in labeled packs (e.g., 5, 10, 25, 50, 100 pellets), enabling flexible allocation across multiple assay runs and experimental conditions.

• Solubility: Generally soluble in common organic solvents such as ethanol, DMSO, and acetone, supporting controlled extraction into solution for chromatographic, spectrometric, or receptor‑binding studies.

• Storage Conditions: Store in a cool, dry, light‑resistant, low‑humidity environment; keep tightly sealed in moisture‑resistant, vacuum‑sealed, or foil‑based packaging and, where feasible, at 2–8°C to help preserve chemical stability and minimize degradation over time.

Laboratory Use Context

1V‑LSD Pellets – 225mcg are intended exclusively for in‑vitro, analytical, and non‑clinical research, including lysergamide stability and decomposition studies, receptor‑binding assays, chromatographic method development, and analytical toxicology or forensic‑laboratory reference‑material work. The standardized pellet format supports reproducible mass loading, clean extraction into solvents, and straightforward documentation of sample preparation steps, making it especially useful for laboratories focused on structure–activity relationships (SAR), pharmacological profiling, or method‑validation projects involving N1‑acyl lysergamides. This product must not be used in any human or animal‑focused therapeutic, preventive, or diagnostic context and is reserved solely for lawful, laboratory‑based experimentation conducted by qualified personnel under applicable research‑guideline frameworks.

Quality & Testing

To support rigorous, reproducible science, each batch of 1V‑LSD Pellets – 225mcg is accompanied by COA‑based documentation, including batch number, purity estimates, and a summary of the analytical methods used for characterization where available. Multi‑method verification such as chromatographic profiling, spectrometric analysis, and additional physicochemical tests helps define the material’s profile and reinforces traceability, supporting E‑E‑A‑T‑aligned sourcing for research institutions and analytical laboratories. Clear labeling and batch‑specific records are designed to give laboratories confidence that each pellet unit is consistent, well‑defined, and suitable for tightly controlled experimental work involving lysergamide reference standards.

Shipping & Handling

Orders are discreetly packaged in neutral, light‑resistant, moisture‑resistant, and often vacuum‑sealed materials to help maintain the integrity of the lysergamide pellets during transit. Discreet worldwide shipping is offered where permitted by local regulations, with batch‑aware handling and tracking features that support secure delivery and logistical transparency. Packaging is designed to minimize exposure to heat, humidity, and physical shocks, further supporting the stability of the material and ensuring that each pellet remains intact, uncontaminated, and chemically sound upon arrival at the laboratory.

Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used in any human or animal therapeutic context. 1V‑LSD Pellets – 225mcg are strictly reserved for lawful laboratory or analytical research conducted by qualified personnel in accordance with applicable local, national, and international regulations. The legal status of 1V‑LSD and related lysergamides varies significantly by jurisdiction, and it is the responsibility of the purchaser to verify compliance with all relevant laws before ordering, receiving, storing, or handling this material.